Despite the high frequency of observed KRAS gene mutations, primarily in pancreas, lung, and colon cancer, RAS (K-, N-, H-) gene mutations are also widely prevalent in many other cancer types, which led to the notion that they contribute to oncogenesis in approximately 20% of human cancers. Here, KRAS is linked to colonic neoplasm.